FIELD: medicine.
SUBSTANCE: there is offered the application of protein and/or peptide fractions containing at least 10.8 wt % of aspartate (or containing 12.0-40 wt % of aspartate per total protein fraction) for preparing a nutritional composition for plasma glucose level control and/or digestive insulin sensitivity enhancement in mammals, containing glucose (versions) and applicable nutritional compositions. It is shown that high amounts of aspartate, especially with the relative absence of glutamate equivalents promote glucose absorption in peripheral cells and improve a hepatic reaction on dietary glucose uptake. The nutritional composition contains protein, preferentially recovered from soya or milk and additionally enriched with aspartate in mass ratio of aspartate equivalents and glutamate equivalents (asp:glu) within 0.41:1 to 5:1.
EFFECT: enabled favourable effect on blood glucose levels in a patient suffering hyperglycemia and/or insulin resistance.
27 cl, 2 dwg, 2 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
PREPARATION FOR APPLICATION OF ASPARTATE AND VITAMIN B12 OR BIOTINE FOR KETONE BODIES REGULATION | 2005 |
|
RU2633071C2 |
PREVENTION OR TREATMENT OF EXCESS WEIGHT AND OBESITY FOR PATIENTS WITH TYPE 2 DIABETES | 2011 |
|
RU2619223C2 |
CARBOHYDRATE COMPOSITION FOR EVEN REACTION TO GLUCOSE | 2006 |
|
RU2413428C2 |
NUTRITIONAL COMPOSITION FOR IMPROVEMENT OF MUSCLE FUNCTIONS AND DIURNAL ACTIVITY | 2009 |
|
RU2506825C2 |
USE OF GALACTOOLIGOSACCHARIDES FOR INCREASING BODY INSULIN SENSITIVITY | 2007 |
|
RU2469557C2 |
METHOD FOR PRODUCTION OF SLOWLY DIGESTIBLE CARBOHYDRATES | 2007 |
|
RU2462044C2 |
APPLICATION OF NUTRIENT COMPOSITION FOR MUSCULAR FUNCTION AND DAILY ACTIVITY IMPROVEMENT | 2009 |
|
RU2636162C2 |
DIETARY FIBER FOR APPLICATION WHILE TREATING ADVERSE EFFECTS OF NUTRITION OR MEDICINAL AGENT ON GASTROINTESTINAL TRACT | 2013 |
|
RU2637133C2 |
PRODUCT FOR USE IN THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF A NEGATIVE EMOTION OR INTROVERT BEHAVIOUR | 2013 |
|
RU2657530C2 |
NUTRITIVE COMPOSITION FOR MAMMAL IMMUNE SYSTEM IMPROVEMENT | 2009 |
|
RU2525429C2 |
Authors
Dates
2010-10-27—Published
2005-07-18—Filed